Dynavax Technologies Corporation

10/24/2024 | Press release | Distributed by Public on 10/24/2024 14:05

Initial Statement of Beneficial Ownership - Form 3

Ownership Submission
FORM 3
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0104Expires:January 31, 2005Estimated average burden hours per response...0.5
1. Name and Address of Reporting Person *
Deep Track Biotechnology Master Fund, Ltd.
2. Date of Event Requiring Statement (Month/Day/Year)
2024-10-22 		3. Issuer Name and Ticker or Trading Symbol
DYNAVAX TECHNOLOGIES CORP [DVAX]
(Last) (First) (Middle)
C/O WALKERS CORPORATE LIMITED, , 190 ELGIN AVENUE
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner
_____ Officer (give title below) _____ Other (specify below)
5. If Amendment, Date Original Filed(Month/Day/Year)
(Street)
GEORGE TOWN E9 KY1-9001
6. Individual or Join/Group Filing(Check Applicable Line)
___ Form filed by One Reporting Person
_X_ Form filed by More than One Reporting Person
(City) (State) (Zip)
Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security 2. Amount of Securities Beneficially Owned 3. Ownership Form: Direct (D) or Indirect (I) 4. Nature of Indirect Beneficial Ownership
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security 2. Date Exercisable and Expiration Date 3. Title and Amount of Securities Underlying Derivative Security 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) 6. Nature of Indirect Beneficial Ownership
Date Exercisable Expriation Date Title Amount or Number of Shares

Reporting Owners

Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
Deep Track Biotechnology Master Fund, Ltd.
C/O WALKERS CORPORATE LIMITED,
190 ELGIN AVENUE
GEORGE TOWN, E9KY1-9001



Deep Track Capital, LP
200 GREENWICH AVE, 3RD FLOOR

GREENWICH, CT06830



KROIN DAVID
200 GREENWICH AVE, 3RD FLOOR

GREENWICH, CT06830



Signatures

Deep Track Biotechnology Master Fund, Ltd. /s/ David Kroin, Director 2024-10-24
**Signature of Reporting Person Date
/s/ Deep Track Capital, LP /s/ David Kroin, Managing Member of the General Partner of Deep Track Capital, LP 2024-10-24
**Signature of Reporting Person Date
/s/ David Kroin 2024-10-24
**Signature of Reporting Person Date

Explanation of Responses:

(*) If the form is filed by more than one reporting person, see Instruction 5(b)(v).
(**) Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) In addition to Deep Track Biotechnology Master Fund, Ltd., a Cayman Islands exempted company ("DTBMF"), this Form 3 is being filed jointly by Deep Track Capital, LP, a Delaware limited partnership ("Deep Track LP"), and David Kroin, a citizen of the United States of America and the managing member of the general partner of Deep Track LP (together with DTBMF and Deep Track LP, the "Reporting Persons"). Each of the Reporting Persons may be deemed to have a pecuniary interest in the securities reported on this Form 3 (the "Subject Securities"). Each of the Reporting Persons disclaims any beneficial ownership of any of the Subject Securities, except to the extent of any pecuniary interest therein.
(2) Each of the Reporting Persons may be deemed to have the shared power to vote or direct the vote of (and the shared power to dispose or direct the disposition of) all of the Subject Securities.
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.